Bodycote has quietly delivered a 74.8% return over the past three years, yet the real story now is whether the current £9.16 share price lines up with the cash the business is expected to generate. With a recommended cash acquisition progressing in the background, the stock's recent rise puts extra focus on what its cash flows actually justify.
-
The 74.8% gain over three years puts a lot of accumulated optimism into Bodycote. This raises the question of how fully its future cash flows are already reflected in the price.
-
The approved cash acquisition by Vulcan Alpha Bidco Limited means future cash flows may ultimately be realised by a new owner. Today's valuation therefore rests on how investors weigh that deal against Bodycote's stand alone earning power over time.
-
What if you looked at Bodycote through its earnings instead? See why Bodycote's 26.5x P/E tells a different valuation story .
For investors, the debate is whether Bodycote's current share price is properly supported by the intrinsic value suggested by its cash flows.
If you are weighing Bodycote against other opportunities where valuation is anchored on future cash generation, it can help to compare it with companies in the 11 high quality undervalued stocks .
Does Bodycote Look Undervalued on Cash Flow?
The Discounted Cash Flow (DCF) model here focuses on the cash Bodycote can return to shareholders over time. Latest twelve month free cash flow sits at about £63.8m, and the projections assume that this pool of cash grows rather than shrinks, with analyst estimates pointing to higher free cash flow by 2028 and then tapering growth beyond that.
Those forecasts feed into a two stage DCF that points to an intrinsic value meaningfully above the current £9.16 share price. This suggests the market is not fully crediting that cash generation profile. The approved cash acquisition by Vulcan Alpha Bidco Limited, expected to complete in Q1 2027, helps explain why some investors may focus more on the offer terms than on Bodycote's longer term earning power, even though the model is driven by that stream of future free cash flow. Find out what Bodycote could be worth using our Discounted Cash Flow (DCF) estimate .
The Bodycote Narrative: What Would Justify Today's Price?
Narratives pick up where the DCF debate leaves off for Bodycote, by spelling out which paths for growth, margins and earnings would need to play out for the shares to be worth materially more or less than today's price. Each one effectively turns fair value into a clear, testable thesis about how the business develops over time, so you can track how that view changes as new information arrives on Simply Wall St's Community page.
Community views on Bodycote are split between those who see enough contract wins and cost programs to support the price and those who worry margin drag still bites too hard.
Bull case: roughly fairly valued
"Major capacity expansions and upgrades in Bodycote's U.S. aerospace and defense sites are now tied to renewed long term agreements with large Tier 1 customers…"
Discover why this Narrative puts Bodycote at roughly fairly valued .
Bear case: 15% overvalued
"The numbers implied by the current valuation leave limited allowance for ongoing auto and industrial weakness and execution risk around footprint rationalisation and bid activity…"
Explore why this Narrative puts Bodycote at 15% overvalued .
One more Bodycote check that belongs beside the share price
Cash flows and deal terms tell only part of the story, because the people directing Bodycote and the way their rewards are structured can strongly influence how that value is pursued over time. See who runs Bodycote and how they are paid .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include BOY.L .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
